Charm Therapeutics is a London-based company that uses advanced computing and machine learning to develop small molecule therapeutics for cancers. The company has recently received an investment from NVIDIA to fund its rapidly growing organization and to harness the power of NVIDIA’s accelerated computing platform. This investment will enable Charm to use its proprietary DragonFold platform to identify potential new compounds and bring potential new therapies to patients faster.